Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing B-Raf inhibitor (product) | Is a | Product containing protein kinase inhibitor (product) | true | Inferred relationship | Some | ||
| Product containing B-Raf inhibitor (product) | Is a | antineoplastisk middel | false | Inferred relationship | Some | ||
| Product containing B-Raf inhibitor (product) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Substance with B-Raf inhibitor mechanism of action (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing dabrafenib (medicinal product) | Is a | True | Product containing B-Raf inhibitor (product) | Inferred relationship | Some | |
| Product containing vemurafenib (medicinal product) | Is a | True | Product containing B-Raf inhibitor (product) | Inferred relationship | Some | |
| Product containing trametinib (medicinal product) | Is a | True | Product containing B-Raf inhibitor (product) | Inferred relationship | Some | |
| Product containing encorafenib (medicinal product) | Is a | True | Product containing B-Raf inhibitor (product) | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR